Down Rounds, Bridge Notes and Founder-Fraud Claims: Underwriting Startup D&O in India's 2026 Funding Reset

When a Series B founder buys directors and officers (D&O) liability cover in India, the risk in their head is usually an employment dispute or a regulatory notice. The risk that actually triggers a seven-figure defence spend is different. Through the 2026 funding reset, the most expensive startup D&O claims trace to financial misrepresentation that surfaces when money gets tight: investors alleging they were shown inflated projections, accounting irregularities discovered in diligence for a down round, or a board accused of approving spend while runway figures were quietly wrong.

The macro picture makes this concrete. Indian startup funding has stayed well below its 2021 peak through the current reset, with year-on-year falls reported across recent quarters. Cohorts that raised at 2021 multiples are now closing down rounds, issuing bridge notes, or winding up. A down round is not just a lower price. It is a forensic event. New investors run harder diligence, existing investors who get diluted look for someone to blame, and anti-dilution and preference mechanics get litigated.

The Indian reference cases are well known to any LP. GoMechanic publicly admitted serious errors in financial reporting after an external review found that a subset of its service centres had overstated revenue; SIDBI and other limited partners began grilling the backing VCs on their diligence, and investors wrote the holding down before a rescue deal at a steeply cut valuation. BharatPe and Zilingo added founder-conduct and revenue-inflation episodes to the same memory bank. Underwriters read these as base rates, not anecdotes.

Brokers should be able to explain, in plain terms, why the down round itself raises claim probability. It is not about valuation pride. It is about who has standing to sue and what they can point at.

The mechanics that generate claims:

• Diluted prior investors. A down round can crush the economics of an earlier round. Where preference and anti-dilution terms are contested, prior holders allege the board engineered the price or failed to run a fair process. That is a breach-of-fiduciary-duty theory aimed straight at directors.
• Diligence-discovered irregularities. Incoming investors run quality-of-earnings work that earlier rounds skipped. Revenue recognition that was generous in a bull market reads as misstatement in a buyer's market. Once a number is restated, every prior representation becomes a potential misrepresentation claim.
• Runway and going-concern disclosures. Boards that approved hiring or marketing against a runway figure later shown to be optimistic face allegations they misled stakeholders or traded while effectively insolvent.
• Down-and-out conversions. Bridge notes that convert at punitive discounts, or that are recharacterised in a dispute, drag note-holders into the cap table as aggrieved parties.

The trigger is rarely the down round in isolation. It is the combination of a price cut and a financial number that does not survive fresh scrutiny. Clean accounting through a down round is the single strongest defence a founder can hold. This is why a 2026 underwriter treats the funding stage and the direction of the last round as live rating factors, not background colour. A flat or up round with audited numbers is a different risk from a 60% down round with management accounts only.

The startup D&O proposal form has quietly changed. The questions that used to be box-ticks now drive the quote, the retention and the exclusions. Brokers preparing a submission should pre-empt all of them.

The live underwriting questions:

1. Audit posture. Are the financials audited, reviewed, or management-prepared? Who is the auditor, and has there been an auditor change in the last two years? An unexplained auditor exit is a red flag underwriters price hard, because it preceded several known blow-ups.
2. Board composition and independence. Is there a genuinely independent director, a constituted audit committee, and documented board minutes? A founder-controlled board with no independent oversight signals concentration risk on conduct.
3. Revenue recognition policy. How is GMV versus net revenue reported to investors, and is the same basis used internally and externally? Mismatched reporting bases sit behind most inflation allegations.
4. Runway and forecast governance. Who approves the cash forecast, how often is it revised, and are board decisions tied to a current runway number?
5. Related-party transactions. Any loans to or from founders, vendor relationships with insiders, or expense practices that could read as misappropriation. The BharatPe episode, where a founder faced allegations of misusing company expense accounts, is exactly the pattern this question screens for.
6. Prior funding history. Direction of the last round, any restatement, and whether earlier investors have written down their holding. A recent down round with a contested cap table is the single fact most likely to drive a loading or a tighter carve-out.

The practical payoff is direct. A founder who can hand over audited accounts, an audit-committee charter, and board minutes that show runway being tracked will often secure cleaner terms than a better-funded peer who cannot. Governance evidence beats balance-sheet size at the conduct layer, because the insurer is pricing the probability of a misrepresentation claim, not the size of the company.

The funding reset shows up in four places on the schedule: limit adequacy, retention, the conduct and fraud carve-outs, and severability. A broker who only negotiates premium has missed the points that decide whether a claim is paid.

Limit and Side A. Private-company startup programmes carry combined Side A, B and C limits, so the company's own indemnification and securities-style exposure share the tower with the directors' personal protection. In a distressed company, the entity may be unable to indemnify, which is exactly when Side A (non-indemnifiable loss, paid directly to individuals) earns its keep. For founders at real down-round risk, ring-fencing dedicated Side A capacity matters more than headline limit.

Retention. Expect higher retentions on the entity (Side C) layer for venture-backed companies with thin audit trails. The retention is where the insurer prices the probability that early claim costs are the company's to bear.

Fraud and conduct exclusions. This is the battleground. D&O policies exclude deliberate fraud and illegal personal profit, but the protection lives in two qualifiers: whether the exclusion bites only on a final, non-appealable adjudication of wrongdoing, and whether defence costs are advanced until that point. A weak wording lets the insurer step away on mere allegation. After GoMechanic-type episodes, some insurers push broader financial-misrepresentation carve-outs or specific runway-disclosure exclusions. Resisting those, or at least narrowing them to conduct established by judgment, is the core broking task.

Severability. If one founder commits fraud, severability decides whether the innocent co-founders and independent directors keep their cover. Full severability of the application and the conduct exclusion is what stops one bad actor voiding the whole programme. For a venture board, this clause is not boilerplate; it is the reason the independent director agreed to serve.

D&O, like all Indian insurance contracts, runs on utmost good faith. For a startup mid-reset, that doctrine is not abstract. The proposal form is the document an insurer will reread line by line if a misrepresentation claim lands, and any gap between what was disclosed and what the company knew becomes the insurer's exit.

The practical exposure points:

• Known circumstances. If the founder is aware of an investor dispute, a regulatory query, a whistleblower complaint, or a brewing restatement at the time of proposal, that is a known circumstance. Failing to disclose it lets the insurer deny the related claim and potentially void the policy. The instinct to present a clean story into a renewal is precisely the instinct that destroys cover.
• The application as evidence. Financial figures stated in the proposal become representations. If they later prove inflated, the insurer can argue the contract was induced by misrepresentation, separate from any conduct exclusion.
• Warranties versus disclosures. Brokers should fight to have material statements treated as disclosures (which require materiality and inducement to bite) rather than strict warranties (which can void on any inaccuracy).

The Sarvada view: a startup that treats the proposal form as a marketing document is buying a policy that will not respond when it matters most.

The single highest-impact thing a broker can do for a venture-backed client in 2026 is assemble a governance file before approaching the market. Underwriters reward evidenced governance with cleaner wordings, narrower carve-outs and lower retentions, because evidence lowers their assessment of conduct risk. The file is also reusable at every renewal and every new round.

What the file should contain:

1. Latest audited financials plus the auditor's name and tenure, with a one-line explanation of any auditor change.
2. Board pack sample: a redacted set of recent minutes showing the board actually discussing runway, related-party items and major spend approvals.
3. Audit-committee charter and the identity of the independent director or the plan to appoint one.
4. Revenue-recognition note: a short statement of how revenue and GMV are reported, confirming internal and investor reporting use the same basis.
5. Cap-table and funding summary: stage, direction of the last round, anti-dilution and preference terms, and any bridge notes outstanding.
6. Disclosure schedule: an honest list of known circumstances, disputes and queries, dated.

For the founder, this file is not insurance admin. It is the same artefact that wins the next term sheet, so the work is dual-purpose. For the broker, presenting it converts a thin, defensive submission into one the underwriter can say yes to without padding the wording with carve-outs. The broker who walks in with this file is negotiating from governance strength; the broker who walks in with a one-page proposal is accepting whatever exclusions the market wants to write.

D&O risk is not static across a startup's life; it steps up at each round, and the cover should step with it. Brokers advising founders through the 2026 reset can map the programme to the stage rather than selling a fixed limit.

Seed to Series A. The exposure is mostly investor representations: pitch decks, term-sheet promises and early reporting. Cover can be modest, but severability and a clean conduct-exclusion wording should be in from day one, because the cheapest moment to fix wording is before any claim exists. Insist defence costs are advanced.

Series B to C. Headcount, regulatory exposure and the cap table all expand. This is the stage where down-round risk becomes real if the multiple was rich. Increase Side A capacity, tighten the financial-misrepresentation carve-out, and review retention against the entity's ability to indemnify. Add employment-practices cover deliberately rather than relying on a thin extension.

Pre-IPO or distressed. A company heading to a public listing faces securities-style exposure and should look at the listed-company D&O architecture, including IPO-related cover. A company heading the other way, into a down round or wind-down, needs the opposite emphasis: maximal non-indemnifiable Side A for individuals, run-off provisions, and absolute clarity that defence costs flow on allegation.

Matching the structure to the stage, and refusing to let the conduct carve-out widen as the company gets riskier, is the practitioner skill the reset is rewarding.

Two structural forces shape how startup D&O is priced in India through 2026, and brokers should factor both into renewal timing and market selection.

First, capacity for venture-backed conduct risk is selective. A handful of Indian insurers and the global managing-general-agent channels write meaningful private-company D&O, and several reinsurers behind them have grown cautious about Indian startup financial-misrepresentation exposure after the well-publicised governance episodes. That caution shows up as wording tightening (broader fraud carve-outs, runway-disclosure exclusions) rather than headline rate spikes. The practical consequence is that wording, not premium, is where a venture client wins or loses, and that a broker who can present governance evidence has genuine bargaining power to keep the wording open.

Second, the regulatory frame is moving towards more disclosure, not less. SEBI's tightening of governance and disclosure expectations, the broader accountability themes that LPs like SIDBI now press on AIFs after GoMechanic, and the general direction of corporate-conduct enforcement all raise the baseline of what directors are expected to know and disclose. As the standard of care rises, so does the surface area for breach-of-duty allegations, which feeds back into D&O claims frequency. IRDAI's continuing push on policyholder-friendly wordings and clearer claims handling helps on the back end, but it does not soften the conduct exclusions that decide founder claims.

The combined message for brokers: place early in the renewal cycle, lead with a governance file, treat the fraud and severability clauses as the real negotiation, and counsel founders that audited numbers and an independent director are worth more to their insurability than another funding headline. In a reset, insurability follows governance, and the broker who makes that case is selling the founder something more durable than a certificate.